Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2000
11/08/2000EP1049717A2 Antibodies against human il-12
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049711A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049699A1 Azolo triazines and pyrimidines
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049490A2 Method for inhibiting cd95-independent apoptosis in aids
11/08/2000EP1049489A1 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
11/08/2000EP1049483A1 Method for treating inflammatory diseases using heat shock proteins
11/08/2000EP1049471A1 Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272882A Chimeric polypeptide comprising fragment B of shiga toxin and peptides of therapeutic interest
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1272792A Herbal extract composition and method with immune-boosting capability
11/08/2000CN1272784A Medicinal compositions for application to mucosa
11/08/2000CN1272365A Physiological active material
11/08/2000CN1058296C Antibody heteroconjugates for use in regulation lymphocyte activity
11/07/2000US6143876 Immunogenic antigenic epitope which is a member of a binding couple; for production of antibodies with increased affinity; diagnosis; treatment; vaccines; viricides against human immunodeficiency virus
11/07/2000US6143867 Amino acid sequence; for diagnosis, prevention, and treatment of late-phase allergic/inflammatory reactions, eosinophilias, parasitic infections, conditions associated with placental derived-basic protein accumulation in pregnancy
11/07/2000US6143775 Physical form of zafirlukast; asthma
11/07/2000US6143770 Mixtures of tocotrienol and nicotinic acid
11/07/2000US6143751 Pyridine derivatives and pharmaceutical compositions containing them
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143728 Guanylhydrazones useful for treating diseases associated with T cell activation
11/07/2000US6143724 Used for treatment, improvement and prevention of inflammation and diseases accompanying inflamation
11/07/2000US6143722 To controll uterine contractions in treating preterm labor
11/07/2000US6143551 Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria
11/07/2000US6143544 Human lysophospholipase
11/07/2000US6143331 Homogenizing using aqueous solution; separation; ultrafiltration
11/07/2000US6143329 Aqueous-based pharmaceutical composition
11/07/2000US6143297 Immunizing a mammals; forming antibodies
11/07/2000US6143273 Useful as immunosuppressants, as well as antibodies capable of preventing the specific binding of the lag-3 protein to major histocompatibility complex class ii molecules as immunostimulants
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2024767C Interferon-gamma receptor fragment and its production
11/02/2000WO2000065069A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000WO2000065068A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000WO2000065060A2 Dna sequence and recombinant production of a graminae allergen
11/02/2000WO2000065058A1 Method for down-regulating il5 activity
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065051A1 Pollinosis-associated gene 627
11/02/2000WO2000065050A1 Pollinosis-associated gene 795
11/02/2000WO2000065049A1 Pollinosis-associated gene 513
11/02/2000WO2000065048A1 Pollinosis-associated gene 581
11/02/2000WO2000065046A1 Pollinosis-associated gene 373
11/02/2000WO2000065045A1 Pollinosis-associated gene 419
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000064938A2 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064870A1 3-methylated vitamin d derivatives
11/02/2000WO2000064869A1 Vitamin d analogues and their pharmaceutical use
11/02/2000WO2000064488A2 Somatic transgene immunization and related methods
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
11/02/2000WO2000064481A1 Controlled release of growth factors from heparin containing matrices
11/02/2000WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
11/02/2000WO2000064471A1 Model membrane systems
11/02/2000WO2000064467A1 Inhibition of proteasome function induces programmed cell death in endothelial cells
11/02/2000WO2000064465A1 Death domain containing receptors
11/02/2000WO2000064458A2 Method for inducing a donor tolerance in the human body
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000041508A3 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000037504A9 Human monoclonal antibodies to ctla-4
11/02/2000WO2000033878A3 Stabilization of macrolides
11/02/2000WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
11/02/2000EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048299A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/02/2000EP1048298A2 Mixed chimerism and tolerance
11/02/2000EP1047787A1 Human calcineurin b-like protein
11/02/2000EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta)
11/02/2000EP1047770A1 Histidine kinase
11/02/2000EP1047714A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047688A1 Thiophene nitrone compounds
11/02/2000EP1047683A1 Thioether furan nitrone compounds
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047457A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP0790059A4 Means for treating auto-immune diseases and method of treatment
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371165A1 Vitamin d analogues and their pharmaceutical use
11/02/2000CA2371114A1 Death domain containing receptors
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
1 ... 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 ... 1172